Home ›
Entities
› academia
› Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma
Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma
Research article (eJHaem, 2020) · cited 13× · AI/ML
Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma
Summary
Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma is a scholarly article[1].
Key Facts
Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma. Retrieved May 24, 2026, from https://4ort.xyz/entity/overall-survival-with-oral-selinexor-plus-lowdose-dexamethasone-versus-realworld-therapy-in-tripleclassrefractory-multip
MLA“Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/overall-survival-with-oral-selinexor-plus-lowdose-dexamethasone-versus-realworld-therapy-in-tripleclassrefractory-multip.
BibTeX@misc{4ortxyz_overall-survival-with-oral-selinexor-plus-lowdose-dexamethasone-versus-realworld-therapy-in-tripleclassrefractory-multip_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma}}, year = {2026}, url = {https://4ort.xyz/entity/overall-survival-with-oral-selinexor-plus-lowdose-dexamethasone-versus-realworld-therapy-in-tripleclassrefractory-multip}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma — https://4ort.xyz/entity/overall-survival-with-oral-selinexor-plus-lowdose-dexamethasone-versus-realworld-therapy-in-tripleclassrefractory-multip (retrieved 2026-05-24)
